Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Rudolf Benz(Kantonsspital Münsterlingen), Georg Stüssi(Institute of Oncology Research), Daniel Rauch(Washington University in St. Louis), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Felicitas Hitz(Kantonsspital St. Gallen), Kornelius Arn(Luzerner Kantonsspital), Alix Stern(Hospital Neuchâtel), Thomas Pabst(University Hospital of Bern), Sabine Blum(University of Lausanne), Ulrich Mey(Kantonsspital Graubünden), U Hess(Université Paris Cité), Simona Berardi(Swiss Group For Clinical Cancer Research), Urban Novak(University of Bern), Mario Bargetzi(Kantonsspital Aarau), Nathan Cantoni(Kantonsspital Aarau), Martin Andres(University of Bern), Elena Bianchi-Papina(Institute of Oncology Research), Andreas Lohri(Kantonsspital St. Gallen), Michaël Baumann(Kantonsspital St. Gallen), Yves Chalandon(University of Geneva), Anita Feller, Reinhard Zenhaeusern, Qiyu Li(First Hospital of China Medical University), Jakob Passweg(University Hospital of Basel)
Cited by 31
Related Papers
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|568
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396